1. What Is the Cancer Registry Market?
The Cancer Registry Market covers software platforms and data management services for population-based and hospital-based cancer registries that systematically collect, manage, and analyse cancer incidence, treatment, and outcomes data. Cancer registry encompasses hospital cancer registry software, central cancer registry platforms, cancer case abstraction services, and registry data analytics tools. Market dynamics reflect national cancer surveillance programme expansion, electronic health record integration with registry data extraction, and real-world evidence analytics demand using registry data for clinical and regulatory decision support.
2. Cancer Registry Market Size & Forecast
3. Emerging Technologies
- AI-assisted cancer case abstraction using NLP to extract cancer diagnosis and staging data from pathology reports are advancing as automation tools. Growing adoption at hospital cancer registries is driven by manual abstraction labour cost reduction requirements.
- Cancer registry interoperability standards enabling data sharing between hospital and central population registries are advancing as data integration tools. Growing adoption is driven by national cancer surveillance completeness requirements.
- Real-world evidence analytics platforms querying linked registry and claims data for drug effectiveness studies are advancing as regulatory tools. Growing adoption at pharmaceutical companies is driven by FDA real-world evidence submission requirements.
- Mobile cancer registry reporting tools enabling physician abstraction at point of care are advancing as data capture tools. Growing adoption at community cancer programmes is driven by timely registry submission requirements.
Such innovations are driving change across adjacent industries too. Discover more in our Oncology Care Model Market.
4. Key Market Opportunity
The leading opportunity in the Cancer Registry Market is the EHR-integrated hospital cancer registry software sub-market, where modern platform replacement of legacy registry software drives commercial licensing revenue. State and national central cancer registry platform modernisation creates a government contract revenue opportunity. Real-world evidence analytics creates a high-margin data analytics revenue channel as pharma and regulatory customers query registry data assets. Asia Pacific cancer registry creates geographic expansion as India, China, and Southeast Asian national cancer registry programmes expand surveillance coverage.
5. Top Companies in the Cancer Registry Market
The following organisations hold leading positions in the Cancer Registry Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Elekta (MOSAIQ Registry)
- Danaher (Cerner HealtheRegistries)
- NCI (SEER)
- C/Net Solutions
- Mediware
- Medearis
- Varian Medical (Aria Registry)
- JourneyWorks
- Iqvia (Oncology Registry)
- McKesson Specialty Health
6. Market Segmentation
The Cancer Registry Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Registry Type | Hospital-Based Population-Based National State Central Research Registry |
| By Solution | Registry Software Case Abstraction Analytics Platform EHR Integration |
| By End User | Hospital Cancer Programme State Health Department National Agency Academic |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Cancer Registry Market trajectory over the forecast period:
SEER Programme Achieves Coverage of 48 Percent of US Cancer Incidence Through 21 Registry Regions.NCI SEER Surveillance Epidemiology End Results programme achieving 48 percent US cancer incidence coverage through 21 population-based registries in 2024 demonstrates the largest national cancer surveillance system globally. SEER data enabling 50-year trend analysis of US cancer incidence and survival demonstrates the longitudinal registry value for population cancer science.
State Cancer Registry Software Upgrade to EHR Integration Reduces Manual Case Abstraction by 60 Percent.Modern cancer registry platforms integrating with Epic, Cerner, and Meditech EHR systems automating electronic cancer case reporting in 2024 demonstrate the efficiency impact of EHR-integrated registry. EHR-to-registry automated case reporting reducing manual abstraction labour by 60 percent demonstrates the cost efficiency driving registry software modernisation.
Real-World Evidence Cancer Registry Analytics Support FDA Drug Approval Submissions.FDA accepting cancer registry real-world evidence from SEER-Medicare and hospital registry data in two oncology drug approval submissions in 2024 demonstrates the regulatory value of registry analytics. Cancer registry real-world evidence supplementing clinical trial data for post-market surveillance and label expansion demonstrates the commercial analytics value beyond public health surveillance.
For related market intelligence, see the Lung Cancer Therapeutics Market.
8. Segmental Analysis
By registry type, the Hospital-Based Cancer Registry segment dominated the Cancer Registry Market in 2025. Representing the largest software revenue category as 1,500-plus ACOS-accredited US cancer programmes maintain required hospital registries. The Population-Based National Registry segment is the fastest-growing category, advancing as national cancer surveillance programme expansion in low and middle-income countries drives new registry platform investment.
By solution, the EHR-Integrated Registry Software segment dominated in 2025 by modernisation spend.
By end user, the Hospital Cancer Programme segment dominated the Cancer Registry Market in 2025, as ACOS-accredited cancer programme registry reporting obligations generate the largest institutional cancer registry platform deployment base. State Health Department is the fastest-growing end-user category, driven by CMS quality reporting requirements and growing population health analytics programmes expanding state-level cancer incidence surveillance.
9. Regional Analysis
Regional demand patterns across the Cancer Registry Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Cancer Registry Market in 2025, holding 51.7% of the global market. NCI SEER programme infrastructure, state cancer registry networks, and hospital cancer programme accreditation requirements are driving systematic cancer incidence tracking, outcome reporting, and population health analysis across comprehensive registry systems. CMS cancer quality reporting requirements and ACOS hospital cancer programme accreditation registry obligations are encouraging healthcare providers to invest in cancer registry data management platforms. High cancer diagnosis volumes, established public health surveillance infrastructure, and strong cancer research investment requiring population-level data are generating strong regional cancer registry demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 11.45% during the forecast period. National cancer registry programmes across Germany, France, the United Kingdom, Italy, and Sweden are expanding coverage, improving data quality, and increasing adoption of electronic cancer registry platforms for population health surveillance. European Network of Cancer Registries coordination and growing EU cancer control plan investment in surveillance infrastructure are encouraging member state registry modernisation. Rising cancer incidence, growing demand for population-level cancer outcomes data, and increasing use of registry data for clinical research are generating European cancer registry platform demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Cancer Registry Market was valued at USD 2.79 Bn in 2025 and is projected to reach USD 6.22 Bn by 2034, growing at a CAGR of 9.3% over the 2026–2034 forecast period.
The Cancer Registry Market is projected to grow at a CAGR of 9.3% from 2026 to 2034.
North America accounted for the largest share of the Cancer Registry Market in 2025, holding 51.7% of the global market.
The leading companies in the Cancer Registry Market include Elekta (MOSAIQ Registry), Danaher (Cerner HealtheRegistries), NCI (SEER), C/Net Solutions, Mediware, Medearis, Varian Medical (Aria Registry), JourneyWorks, Iqvia (Oncology Registry), McKesson Specialty Health.
Seer programme achieves coverage of 48 percent of us cancer incidence through 21 registry regions.
By registry type, the Hospital-Based Cancer Registry segment dominated the Cancer Registry Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.